We are live on ! Find out more
LMAT icon

LeMaitre Vascular

307 hedge funds and large institutions have $1.95B invested in LeMaitre Vascular in 2024 Q4 according to their latest regulatory filings, with 43 funds opening new positions, 123 increasing their positions, 96 reducing their positions, and 25 closing their positions.

New
Increased
Maintained
Reduced
Closed

72% more first-time investments, than exits

New positions opened: 43 | Existing positions closed: 25

28% more repeat investments, than reductions

Existing positions increased: 123 | Existing positions reduced: 96

24% more call options, than puts

Call options by funds: $332K | Put options by funds: $267K

5% more funds holding

Funds holding: 291307 (+16)

0.82% more ownership

Funds ownership: 93.45%94.27% (+0.82%)

0% more capital invested

Capital invested by funds: $1.95B → $1.95B (+$3.2M)

0% more funds holding in top 10

Funds holding in top 10: 44 (0)

Holders
307
Holders Change
+16
Holders Change %
+5.5%
% of All Funds
4.04%
Holding in Top 10
4
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.05%
New
43
Increased
123
Reduced
96
Closed
25
Calls
$332K
Puts
$267K
Net Calls
+$65K
Net Calls Change
-$149K
Name Holding Trade Value Shares
Change
Change in
Stake
AAS
76
Annex Advisory Services
Wisconsin
$2.92M +$170K +1,769 +6%
RP
77
Riverwater Partners
Wisconsin
$2.84M -$89K -925 -3%
Citigroup
78
Citigroup
New York
$2.75M +$233K +2,428 +9%
New York State Common Retirement Fund
79
New York State Common Retirement Fund
New York
$2.74M
BNP Paribas Financial Markets
80
BNP Paribas Financial Markets
France
$2.64M +$84K +874 +3%
Wells Fargo
81
Wells Fargo
California
$2.59M +$219K +2,274 +9%
VFA
82
Values First Advisors
Tennessee
$2.44M -$117K -1,216 -4%
Two Sigma Investments
83
Two Sigma Investments
New York
$2.43M -$1.28M -13,279 -33%
HCA
84
Harbor Capital Advisors
Illinois
$2.28M +$65.1K +677 +3%
VHAM
85
Van Hulzen Asset Management
California
$2.24M +$152K +1,576 +7%
NFG
86
Nations Financial Group
Iowa
$2.16M +$136K +1,412 +6%
UBS Group
87
UBS Group
Switzerland
$2.14M +$1.63M +16,982 +273%
LCM
88
Legato Capital Management
California
$2.14M +$45.8K +476 +2%
Prudential Financial
89
Prudential Financial
New Jersey
$2.11M -$155K -1,610 -7%
AllianceBernstein
90
AllianceBernstein
Tennessee
$2.08M +$124K +1,287 +6%
MAM
91
Martingale Asset Management
Massachusetts
$2.03M +$30.9K +321 +1%
JIC
92
Johnson Investment Counsel
Ohio
$2.01M
ORI
93
Oak Ridge Investments
Illinois
$1.94M -$65.1K -677 -3%
AQR Capital Management
94
AQR Capital Management
Connecticut
$1.88M -$254K -2,640 -11%
HWAM
95
Hennion & Walsh Asset Management
New Jersey
$1.84M +$201K +2,094 +12%
Canada Life
96
Canada Life
Manitoba, Canada
$1.79M -$73.1K -760 -4%
California State Teachers Retirement System (CalSTRS)
97
California State Teachers Retirement System (CalSTRS)
California
$1.74M -$21K -218 -1%
D.E. Shaw & Co
98
D.E. Shaw & Co
New York
$1.71M -$3M -31,233 -63%
Deutsche Bank
99
Deutsche Bank
Germany
$1.7M +$553K +5,747 +45%
Two Sigma Advisers
100
Two Sigma Advisers
New York
$1.69M -$692K -7,200 -28%

LMAT Hedge Fund Activity: Q4 2024 in Review

307 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in LeMaitre Vascular (LMAT) for Q4 2024, worth a combined $1.95B — up 0.16% from $1.95B a quarter earlier.

Buyers outnumbered sellers: 43 funds opened new LMAT positions and 25 closed out — a net gain of 18 holders — while 123 added to existing stakes and 96 trimmed.

The largest buyer was BlackRock, adding an estimated $22.8M. The largest seller was Conestoga Capital Advisors, cutting an estimated $27.5M.

  • 307 institutional investors held LeMaitre Vascular (LMAT) as of Q4 2024, up from 291 in Q3 2024.
  • Funds reported $1.95B of LeMaitre Vascular stock for Q4 2024, up 0.16% quarter-over-quarter.
  • 43 funds opened new LeMaitre Vascular positions in Q4 2024 and 25 closed out, a net change of +18 holders.
  • The largest LeMaitre Vascular buyer in Q4 2024 was BlackRock, an estimated $22.8M added.
  • The largest LeMaitre Vascular seller in Q4 2024 was Conestoga Capital Advisors, an estimated $27.5M sold.

Based on aggregated 13F filings for Q4 2024.